宫癌晚期妇女的生存状况和预测因素
Roza Teshome1, Irene Yang2, Edom Woldetsadik3
1Department of Midwifery, School of Nursing & Midwifery, College of Health Sciences, Addis Ababa University, Addis Ababa, Ethiopia.
International journal of women's health
|April 22, 2024
概括
晚期宫癌患者的一年生存率为77%. 影响生存的关键因素包括患者年龄,癌症阶段,贫血和治疗等待时间.
科学领域:
- 妇科瘤学 妇科瘤学
- 癌症生存率研究 癌症生存率研究
- 低收入和中等收入国家的公共卫生.
背景情况:
- 宫癌仍然是全球女性癌症死亡的主要原因,不成比例地影响低收入和中等收入国家.
- 尽管可以预防,但有效的管理需要早期发现,及时治疗和强有力的幸存者护理.
- 幸存者是全面癌症护理的关键,但经常被忽视的组成部分.
研究的目的:
- 评估被诊断患有晚期宫癌的患者的生存状况.
- 为了确定与这种患者队列中存活相关的预后因素.
- 为改善宫癌生存结果的策略提供信息.
主要方法:
- 一项前性队列研究涉及180名晚期宫癌患者,进行了一年.
- 使用卡普兰-梅尔和日志等级测试来评估生存状况.
- 双变量和多变量考克斯回归分析确定了生存的预测因素.
主要成果:
- 晚期宫癌患者的一年累计存活率为77%.
- 根据FIGO阶段的生存率有显著差异,在IIB/IIIA阶段的生存率为100%,而在IVB阶段为56%,IVB阶段为24%.
- 高龄 (>60岁) 与死亡风险增加1.5倍有关;贫血和更长的治疗等待时间也是重要因素.
结论:
- 晚期宫癌患者的一年生存率为77%,这凸显了改善管理的必要性.
- 年龄,FIGO阶段,贫血和治疗延迟是生存的关键决定因素.
- 针对这些因素的有针对性的干预措施对于提高子宫癌存活率至关重要.
相关概念视频
01:21Cancer Survival Analysis
345
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
345
01:20Comparing the Survival Analysis of Two or More Groups
179
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
179
01:24Kaplan-Meier Approach
135
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
135
01:15Assumptions of Survival Analysis
125
Survival models analyze the time until one or more events occur, such as death in biological organisms or failure in mechanical systems. These models are widely used across fields like medicine, biology, engineering, and public health to study time-to-event phenomena. To ensure accurate results, survival analysis relies on key assumptions and careful study design.
125
02:07Tumor Progression
6.3K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.3K
01:20Actuarial Approach
77
The actuarial approach, a statistical method originally developed for life insurance risk assessment, is widely used to calculate survival rates in clinical and population studies. This method accounts for participants lost to follow-up or those who die from causes unrelated to the study, ensuring a more accurate representation of survival probabilities.
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
77